Targeting c‐met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma

Yibin Zhang(Central South University)
Journal of Cellular and Molecular Medicine
October 24, 2018
Cited by 24


Related Papers